How long does Mounjaro take to work?
No clinician has reviewed this page. Label and trial statements are quoted from the FDA label or the trial cited beside them. General guidance is marked as such, and every price carries the date it was verified. That is sourcing, not medical review. What we do and do not check · Who checked the price
Last updated 2026-09-02 — the version of the FDA label this schedule comes from. Read and dated by Alex Seot.
How long does it take for Mounjaro to work?
Mounjaro has no fixed escalation period published in its label, so there is no week number to quote for when it reaches full effect. The dose you stay on is the one to plan around, whatever the label's escalation says. The 11.9% weight loss shown for Mounjaro on this site is not a figure its label prints. The label reports weight in kilograms, and the percentage is those kilograms over the trial's starting weight — arithmetic the label does not do itself. Appetite changes are usually reported within the first weeks, but the trial figure is measured over its full length rather than at any earlier point — the two are different claims and are often quoted as one. Every week of that schedule is billed: $499 a month at maintenance on this site, with its source and the date it was read on its price page.
The schedule, week by week — and what each week costs
Doses and intervals are quoted from FDA prescribing information for Mounjaro (tirzepatide, diabetes label). Prices are the published figure for that dose where the manufacturer prices per step; where it charges one price throughout, the column says so.
| When | Dose | A month at this step | What the label notes |
|---|---|---|---|
| 1–4 | 2.5 mg | $499 — one price throughout | Starting dose. |
| 5 and on | 2.5 mg → 15 mg | $499 — one price throughout | Raised in 2.5 mg steps, each held at least 4 weeks, only if glycemic control needs it. The August 2026 label dropped the fixed move to 5 mg at week 5 and the line that 2.5 mg is not a glycemic-control dose. |
What “working” is being measured
The 11.9% mean weight loss shown for Mounjaro on this site is not a number its label prints. No percentage of body weight appears anywhere on the Mounjaro label, which has no weight-management section: every trial on it is a diabetes trial and reports weight in kilograms. This figure is worked out from the label's own kilograms — 11.2 kg lost from a 93.8 kg mean baseline at week 40 on 15 mg, in SURPASS-2 against semaglutide — and is an arithmetic step the label does not take. That figure is the endpoint of a trial, not a milestone you pass on a particular week — and it is an average across everyone in the trial, so individual results sit on both sides of it.
Appetite change is the thing most people notice first and it is commonly reported in the early weeks — at doses the label itself calls initiation rather than treatment. Conflating that with the trial figure is how “it works in a week” gets written.
The reactions the label lists in at least 5% of patients — nausea, diarrhea, decreased appetite, vomiting, constipation — cluster just after a step up rather than at a steady dose. The full label list →
How much weight by month 3 or 6?
Mounjaro's label has no weight-management trial, so these come from people prescribed it in routine care. These are the earliest figures printed as text or in a table, each with who was counted — which moves the number more than the week does.
| When | Average change | In pounds | Who was counted |
|---|---|---|---|
| Month 3 | −5.9% | about 14 lb | US health-record cohort prescribed tirzepatide in its diabetes-labeled pens, 52% with type 2 diabetes, counted only while they stayed on it. Rodriguez et al., JAMA Internal Medicine, 2024 |
| Month 6 | −10.1% | about 24 lb | US health-record cohort prescribed tirzepatide in its diabetes-labeled pens, 52% with type 2 diabetes, counted only while they stayed on it. Rodriguez et al., JAMA Internal Medicine, 2024 |
| Month 12 | −15.3% | about 37 lb | US health-record cohort prescribed tirzepatide in its diabetes-labeled pens, 52% with type 2 diabetes, counted only while they stayed on it. Rodriguez et al., JAMA Internal Medicine, 2024 |
Pounds are the source's own kilograms converted, or its percentage applied to the average starting weight of the people it counted. Someone who starts lighter loses fewer pounds at the same percentage.
Mounjaro shares its molecule with Zepbound, and the trial run for weight is on Zepbound's label. Zepbound's figures by week →
Everything on Mounjaro
- Mounjaro price and terms →
- What is Mounjaro? →
- Mounjaro cost without insurance →
- Alternatives to Mounjaro →
- Mounjaro coupons and savings cards →
- Mounjaro Savings Card →
- Mounjaro side effects →
- Does Mounjaro make you feel sick? →
- Does Mounjaro cause constipation? →
- Does Mounjaro cause diarrhea? →
- Does Mounjaro make you throw up? →
- Does Mounjaro cause stomach pain? →
- Does Mounjaro cause indigestion? →
- Does Mounjaro take away your appetite? →
- Mounjaro dose schedule →
- How to inject Mounjaro →
- Which labels record what happens when you stop →
- Hair loss: which of the labels name it →
- Alcohol: what the labels say, and what they do not →
- tirzepatide at LillyDirect: the price →
- tirzepatide: every product and price →
- Foundayo vs Mounjaro →
- Mounjaro vs Wegovy pill →
- Compounded semaglutide vs Mounjaro →
- Contrave vs Mounjaro →
- Compounded tirzepatide vs Mounjaro →
- Mounjaro vs Phentermine →
- Mounjaro vs Ozempic →
- Mounjaro vs Qsymia →
- Mounjaro vs Wegovy →
- Mounjaro vs Saxenda →
- Mounjaro vs Zepbound →
- LillyDirect: the seller →
- Mochi Health: the seller →
- Henry Meds: the seller →
- Noom Med: the seller →
- PlushCare: the seller →
- Compounded tirzepatide: the drug →
- Eden: the seller →
- GoodRx for Weight Loss: the seller →
Mounjaro timeline, answered
- How long before Mounjaro starts working?
- Two different things get called "working". Appetite changes are commonly reported within the first weeks, at doses the label describes as initiation rather than treatment. The weight-loss figure people quote is measured over a full trial at the maintenance dose. A page that answers with one number is answering only one of the two questions.
- How much weight can you lose on Mounjaro in 3 months?
- Mounjaro's label has no weight-management trial, so the figures come from people prescribed it in routine care. The earliest printed figures: month 3, −5.9% (about 14 lb) in a US health-record cohort, counted while on it; month 6, −10.1% (about 24 lb) in the same cohort; month 12, −15.3% (about 37 lb) in the same cohort. Each is an average, and each counts a different group of people.
- Can the schedule be moved faster?
- That is a prescriber's decision and this page does not advise on it. What the label says is the escalation interval it was studied at; going faster is off-label territory and going slower is common where side effects are hard. The reactions the label lists — nausea, diarrhea, decreased appetite, vomiting — are typically worst just after a step up.
- Do I pay for the titration months?
- Yes, every one of them. Mounjaro is $499 a month at maintenance on this site. The months before maintenance are not free trial months; they are billed at the price for that dose.
The schedule is quoted from FDA prescribing information for Mounjaro (tirzepatide, diabetes label), read directly. This page reports what the label says and does not recommend a dose or a schedule; that is a conversation with a prescriber. Information only, not medical advice.